Janiina Kauppinen

At Solid IO, we are transforming oncology and immunotherapy with next-generation organ-on-chip technology powered by advanced bioengineering and AI. Our patient-specific tumor models provide real-time, biologically relevant insights that help oncologists, researchers, and pharmaceutical innovators make precise, informed treatment decisions. By replicating the tumor microenvironment and combining it with computational intelligence, our platform eliminates uncertainty, accelerates drug development, optimizes clinical trials, and expands access to advanced cancer therapies. With Solid IO, the next era of precision oncology begins now. ➡️ Advancing immuno-oncology research ➡️ Bridging science, bioengineering & clinical application ➡️ Optimizing drug development & patient outcomes with AI-supported insights WHY SOLID IO? ✅ Real-time patient-specific insights — Predict treatment responses before and during therapy. ✅ Faster, more efficient drug development — Reduce trial timelines and optimize biomarker validation. ✅ Transforming immuno-oncology — Unlock next-gen personalized immunotherapies. ✅ Powered by advanced bioengineering & AI — Turning biological complexity into actionable decisions. ✅ Scalable, global impact — Making precision oncology more accessible & clinically relevant. Bringing precision to where it matters most — real-world patient care. WHO WE WORK WITH • Cancer Clinics & Research Centers — Advance breakthrough trials & personalized treatment pathways. • Pharmaceutical & Biotech Companies — Accelerate drug R&D, patient stratification, and regulatory approvals. • Investors & Partners — Drive global expansion and impact in precision medicine. We are seeking visionary partners to push the boundaries of precision oncology. Let’s collaborate to redefine cancer care. Visit our website: www.solid-io.com Partner with us: noora.hujala@solid-io.com Based in Helsinki, Finland | Collaborating Globally

Markkinointiviestinnän palveluyritys Roihu Inc. suunnittelee ja toteuttaa asiakkailleen laadukkaita ja tuottavia markkinointiviestinnän monikanavaisia ratkaisuja. Autamme asiakkaamme liiketoiminnan vahvuuksien muuttamisessa konseptiksi eli tarinaksi, joka kertoo yrityksen kohderyhmilleen tuottamasta arvosta ja palvelusta. Roihu Inc. suunnittelee asiakkaan markkinointiviestinnän ratkaisut yhdistämällä syvällisen markkinointiviestinnän osaamisen liiketoimintaymmärrykseen ja laajaan toimialatuntemukseen. Kokonaisuus ja toimenpiteet suunnitellaan tulevaisuuden kehitystarpeet huomioiden ja pitkäjänteiseen yhteistyöhön panostaen.

At Solid IO, we are transforming oncology and immunotherapy with next-generation organ-on-chip technology powered by advanced bioengineering and AI. Our patient-specific tumor models provide real-time, biologically relevant insights that help oncologists, researchers, and pharmaceutical innovators make precise, informed treatment decisions. By replicating the tumor microenvironment and combining it with computational intelligence, our platform eliminates uncertainty, accelerates drug development, optimizes clinical trials, and expands access to advanced cancer therapies. With Solid IO, the next era of precision oncology begins now. ➡️ Advancing immuno-oncology research ➡️ Bridging science, bioengineering & clinical application ➡️ Optimizing drug development & patient outcomes with AI-supported insights WHY SOLID IO? ✅ Real-time patient-specific insights — Predict treatment responses before and during therapy. ✅ Faster, more efficient drug development — Reduce trial timelines and optimize biomarker validation. ✅ Transforming immuno-oncology — Unlock next-gen personalized immunotherapies. ✅ Powered by advanced bioengineering & AI — Turning biological complexity into actionable decisions. ✅ Scalable, global impact — Making precision oncology more accessible & clinically relevant. Bringing precision to where it matters most — real-world patient care. WHO WE WORK WITH • Cancer Clinics & Research Centers — Advance breakthrough trials & personalized treatment pathways. • Pharmaceutical & Biotech Companies — Accelerate drug R&D, patient stratification, and regulatory approvals. • Investors & Partners — Drive global expansion and impact in precision medicine. We are seeking visionary partners to push the boundaries of precision oncology. Let’s collaborate to redefine cancer care. Visit our website: www.solid-io.com Partner with us: noora.hujala@solid-io.com Based in Helsinki, Finland | Collaborating Globally

Helsinki Partners is a city marketing, investment and talent attraction company owned by the City of Helsinki. Whether you’re looking to set up or expand your company, find quality deal flow and investment opportunities, the best location for your event or congress, or visit or find your new career in Finland’s capital, Helsinki, we are here to help. Our mission: Our mission is to promote the city’s sustainable growth and build Helsinki’s global reputation and brand. We do this by attracting international investments, businesses, talents and visitors, and conducting international sales and marketing. Let us share our secrets: Explore and experience Helsinki like a local with us. We know the city. We know the ecosystem. We know the possibilities. And we are willing to share our secrets. Our history: The City of Helsinki combined the operations of two of its subsidiaries, Helsinki Business Hub and Helsinki Marketing, into a new company named Helsinki Partners. We will continue providing our international clients high quality, tailor-made services. We match people with possibilities: Whether you are an investor, business professional, founder, talent or a visitor, we’ve got you covered. Helsinki is aiming at sustainable growth and is welcoming all partners willing to build a better future together with us. We offer personal service and seek to open up a window into Helsinki. Our services are tailor-made to match your needs, and they are free of charge for foreign companies. Helsinki offers opportunities especially in (but not limited to) -Information and communication technology, with a special focus on artificial intelligence, cyber security, quantum technologies, fintech and edtech -Health, with a specia focus on personalised health & digital health -Smart & clean technologies, with special focus on smart buildings, smart mobility, smart energy and circular economy -Offering support to business event and congress organisers as well as travel trade professionals

In BSV Ventures (formerly known as Baltic Sandbox Ventures), we invest in early-stage R&D-focused individuals and teams solving complex technical challenges with large potential for commercial application.

Vendep Capital is an early stage VC fund focused exclusively on B2B SaaS. With over €111M under management and 12+ years of SaaS investing experience, we partner with ambitious founders from the Nordics and Baltics on their journey from early traction to global scale. We’ve been in your shoes and know the playbook. Beyond capital, we bring hands-on support through our platform, a trusted founder community, and deep SaaS expertise – helping you shorten sales cycles, build winning teams, and raise your next round. Our portfolio includes some of the region’s most promising SaaS scaleups, and we’re always looking to meet founders who share our ambition to build global category leaders.